fda statement on compounded semaglutide Navigating Semaglutide: What Health Care Providers Need to Know FDA says 'no clinical need'
Description
The decision to use both medications simultaneously should be individualized based on the patient's overall metabolic profile, cardiovascular risk, and treatment goals

139 ZhengB.HaoD.GuoH.HeB

Neuropharmacology 2018, 133: 3850

So I was going to ask the question about an equity role

At first, they were extremely hard to get, and patients were having to pay at least $400 a month for prescriptions, a very high price at the time

Administering semaglutide subcutaneously in the thigh is a straightforward procedure that most patients can perform independently at home